New research paves the way for the development of a vaccine for the Tasmanian devil, currently on the brink of extinction because of a contagious cancer.
Plants & Animals
Mar 11, 2013
0
0
Small stretches of DNA in the human genome are known as "pseudogenes" because, while their sequences are nearly identical to those of various genes, they have long been thought to be non-coding "junk" DNA.
Cell & Microbiology
Feb 24, 2013
0
0
Scientists at Karolinska Institutet in Sweden describe in a new study how so-called DNA origami can enhance the effect of certain cytostatics used in the treatment of cancer. With the aid of modern nanotechnology, scientists ...
Bio & Medicine
Sep 13, 2012
0
0
(Phys.org) -- The degree of genetic difference to a tumor is not a factor in Tasmanian devils contracting the facial tumor disease, according to research led by the University of Sydney.
Plants & Animals
Jun 7, 2012
5
0
An international team of scientists has announced a new advance in the ability to target and destroy certain cancer cells.
Biochemistry
Mar 26, 2012
0
0
A common chemotherapy drug has been successfully delivered to cancer cells inside tiny microparticles using a method inspired by our knowledge of how the human immune system works. The drug, delivered in this way, reduced ...
Biotechnology
Sep 12, 2011
0
0
A bacterial strain that specifically targets tumours could soon be used as a vehicle to deliver drugs in frontline cancer therapy. The strain is expected to be tested in cancer patients in 2013 says a scientist at the Society ...
Cell & Microbiology
Sep 5, 2011
7
0
Tiny magnetic discs just a millionth of a metre in diameter could be used to used to kill cancer cells, according to a study published on Sunday.
Bio & Medicine
Nov 29, 2009
4
0
Microscopic magnetic particles have been used to bring stem cells to sites of cardiovascular injury in a new method designed to increase the capacity of cells to repair damaged tissue, UCL scientists announced today.
Bio & Medicine
Aug 17, 2009
0
0
A multi-disciplinary team of scientists from the University of Leicester could be potentially paving the way for the development of a powerful new strategy for both the early diagnosis and treatment of prostate cancer.
Bio & Medicine
Apr 17, 2009
1
0
